At the Sarah Cannon/HealthONE Cancer Network, we continually monitor quality indicators and outcomes to improve patient care. Providing care according to the recommendations of the Commission on Cancer, as well as the National Quality Forum (NQF), the American Society of Oncology (ASCO), and the National Comprehensive Cancer Network (NCCN) , is more likely to result in high quality patient outcomes.


Rose Medical Center is proud of our outcomes on these key cancer program measures. Our multidisciplinary approach with collaboration among physicians, clinicians, and nurse navigators improves communication, coordination of care, and effective treatment for our patients.


100% of women at Rose receive radiation within 1 year of a breast cancer diagnosis


98.7% of women at Rose receive Tamoxifen within 1 year of a breast cancer diagnoses


93.9% of women at Rose have a biopsy done to diagnose breast cancer


100% of colon cancer patients at Rose have at least 12 lymph nodes removed


References: American College of Surgeons, Commission on Cancer, Cancer Program Standards: Ensuring Patient-Centered Care, 2016 Edition, Standard 1.12.

DEFINITION AND REQUIREMENTS

Each year, the cancer committee develops and disseminates a report of patient or program outcomes to the public. The content of the report includes outcome information on 1 or more of the following standards:

  • Standard 4.1 Prevention Programs<
  • Standard 4.2 Screening Programs
  • Standard 4.4 Accountability Measures – these will be the measures that we will use<
  • Standard 4.5 Quality Improvement Measures – these will be the measures that we will use
  • Standard 4.6 Monitoring Compliance with Evidence-Based Guidelines
  • Standard 4.7 Studies of Quality
  • Standard 4.8 Quality Improvements